Virtual Investor R&D Day hosted by Ocuphire (GlobeNewswire) - Jan 5, 2022 - Pres time: Jan 31, 2022; 10:00 AM - 12:00 PM; "Virtual Investor R&D Day for the investment community at which six ophthalmic Key Opinion Leaders (KOLs) from retina, optometry and refractive surgery practices will share their thoughts on three large unmet indications, RM, presbyopia, and DR/DME, addressed by Ocuphire's two late-stage clinical drug assets and provide status updates on the development programs for Nyxol and APX3330."
Live event
|